Link to Full Article BioScience Managers (BSM) is one of Australia’s leading international healthcare investment firms. The CSIRO is Australia’s most loved, respected and revered science and research organisation, responsible for fast Wi-Fi, Aerogard and polymer banknotes among many other notable discoveries. Currently it is working on the first gravitational waves in space, growing gluten-free […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-08-08 00:43:422019-08-15 03:55:36Leading investment firm invests in new CSIRO health technology
Link to Full Article • Total revenue of A$17.0 million for fiscal year 2019 (FY19), an increase of 50% year-over-year • U.S. product sales of A$6.2 million for FY19 • U.S. product sales of A$2.9 million for fourth quarter, an increase of 32% compared to FY third quarter sales Valencia, Calif., USA, and Melbourne, Australia, […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-07-31 05:04:282019-08-05 05:28:05AVITA Medical Reports Fourth Quarter Fiscal 2019 Financial Results and Company Update
Link to Full Article ‘Synthetic Amniotic Membrane’ development project supported by InnovateUK and the UKI2S Accelerator Programme for Technology Development Projects. For many of us, there is hardly any more life-changing disability imaginable than loss of sight. Whether through trauma or disease, the inability to rely on visual cues impacts on all matters of daily […]
Link to Full Article Regulatory approval is the next major hurdle facing Saluda Medical, the biotech company which is led by Cochlear’s former chief technology officer and was responsible for the biggest domestic life sciences capital raising of the last fiscal year. Saluda Medical said in June it had raised $US75 million ($106 million) from […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-07-26 01:04:462019-07-29 01:14:50Regulatory approval next hurdle for Saluda Medical
Link to Full Article Unlike patient-reported motor diaries, PKG distinguishes among different groups of fluctuators and identifies high levels of dyskinesia among patients who deny having dyskinesia symptoms PORTSMOUTH, NH USA, LONDON, UK and MELBOURNE, Australia, July 23, 2019 – Global Kinetics Corporation Ltd. today announced the publication of a study demonstrating that the use […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-07-23 04:53:522019-08-15 05:02:27Data Published in Functional Neurology Demonstrate that Global Kinetics’ Personal KinetiGraph® (PKG®) is Uniquely Positioned to Enable Objective Assessment of Motor Fluctuations in Parkinson’s Disease Patients
Click Link for full Article WHP COMPLETES CLEANROOM PROJECT FOR ADC BIO IN THE UK Production of new anti-cancer drugs at ADC Bio’s North Wales manufacturing plant has been boosted following completion of a new cleanroom facility. The project has been designed and built by WHP. The new GMP cleanroom is part of ADC Bio’s […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-07-18 04:56:262019-07-22 04:57:28ADC BIO’S NEW STATE OF THE ART CLEAN ROOM FACILITY IS NOW READY TO SERVE GLOBAL CUSTOMER DEMANDS!
Link to Full Article Cambridge, UK., 9th July 2019: Arecor Ltd (“Arecor” or “the Company”), the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, today announces that it has signed a further collaboration with a major global pharmaceutical company. Under this […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-07-09 04:28:572019-07-12 04:31:47ARECOR SIGNS A NEW FORMULATION EVALUATION AGREEMENT WITH AN EXISTING PARTNER, A MAJOR GLOBAL PHARMACEUTICAL COMPANY
Link to Full Article Innovative regenerative technology using patients’ own skin cells significantly reduced size of wounds caused by diabetic foot ulcers in all patients Valencia, Calif., USA, and Melbourne, Australia, 01 July 2019 — AVITA Medical (ASX: AVH, OTCQX: AVMXY) a global regenerative medicine company, announced today favorable results from an open-label feasibility study […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-07-01 04:33:102019-07-12 04:44:08RECELL® System Feasibility Study Results for Treatment of Diabetic Foot Ulcers Presented at 11th Annual Congress of the Japanese Society of Limb Salvage & Podiatric Medicine
Link to Full Article A publication in Acta Biomaterialia by a team at Nottingham University, led by Profs Felicity Rose and Cameron Alexander, describes how a thermoresponsive polymer can be incorporated into 3D cell culture scaffolds to facilitate cell release. This thermoresponsive electrospun scaffold system combines the advantages of providing a physiologically relevant environment to maintain a […]
Artarmon, NSW, Australia – June 28, 2019 – Saluda Medical Pty Limited (“Saluda Medical”) today announced that it has secured $75 million in equity financing from Boston Scientific Corporation (NYSE: BSX) and Redmile Group LLC to fund the final stages of development through commercialization of its Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System for […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-06-28 05:20:232019-07-12 05:21:00Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group
Leading investment firm invests in new CSIRO health technology
/in PharmamarkLink to Full Article BioScience Managers (BSM) is one of Australia’s leading international healthcare investment firms. The CSIRO is Australia’s most loved, respected and revered science and research organisation, responsible for fast Wi-Fi, Aerogard and polymer banknotes among many other notable discoveries. Currently it is working on the first gravitational waves in space, growing gluten-free […]
AVITA Medical Reports Fourth Quarter Fiscal 2019 Financial Results and Company Update
/in Avita MedicalLink to Full Article • Total revenue of A$17.0 million for fiscal year 2019 (FY19), an increase of 50% year-over-year • U.S. product sales of A$6.2 million for FY19 • U.S. product sales of A$2.9 million for fourth quarter, an increase of 32% compared to FY third quarter sales Valencia, Calif., USA, and Melbourne, Australia, […]
SYNTHETIC WOUND HEALING MEMBRANE
/in ElectrospinningLink to Full Article ‘Synthetic Amniotic Membrane’ development project supported by InnovateUK and the UKI2S Accelerator Programme for Technology Development Projects. For many of us, there is hardly any more life-changing disability imaginable than loss of sight. Whether through trauma or disease, the inability to rely on visual cues impacts on all matters of daily […]
Regulatory approval next hurdle for Saluda Medical
/in Saluda MedicalLink to Full Article Regulatory approval is the next major hurdle facing Saluda Medical, the biotech company which is led by Cochlear’s former chief technology officer and was responsible for the biggest domestic life sciences capital raising of the last fiscal year. Saluda Medical said in June it had raised $US75 million ($106 million) from […]
Data Published in Functional Neurology Demonstrate that Global Kinetics’ Personal KinetiGraph® (PKG®) is Uniquely Positioned to Enable Objective Assessment of Motor Fluctuations in Parkinson’s Disease Patients
/in GKCLink to Full Article Unlike patient-reported motor diaries, PKG distinguishes among different groups of fluctuators and identifies high levels of dyskinesia among patients who deny having dyskinesia symptoms PORTSMOUTH, NH USA, LONDON, UK and MELBOURNE, Australia, July 23, 2019 – Global Kinetics Corporation Ltd. today announced the publication of a study demonstrating that the use […]
ADC BIO’S NEW STATE OF THE ART CLEAN ROOM FACILITY IS NOW READY TO SERVE GLOBAL CUSTOMER DEMANDS!
/in ADC BioClick Link for full Article WHP COMPLETES CLEANROOM PROJECT FOR ADC BIO IN THE UK Production of new anti-cancer drugs at ADC Bio’s North Wales manufacturing plant has been boosted following completion of a new cleanroom facility. The project has been designed and built by WHP. The new GMP cleanroom is part of ADC Bio’s […]
ARECOR SIGNS A NEW FORMULATION EVALUATION AGREEMENT WITH AN EXISTING PARTNER, A MAJOR GLOBAL PHARMACEUTICAL COMPANY
/in ArecorLink to Full Article Cambridge, UK., 9th July 2019: Arecor Ltd (“Arecor” or “the Company”), the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, today announces that it has signed a further collaboration with a major global pharmaceutical company. Under this […]
RECELL® System Feasibility Study Results for Treatment of Diabetic Foot Ulcers Presented at 11th Annual Congress of the Japanese Society of Limb Salvage & Podiatric Medicine
/in Avita MedicalLink to Full Article Innovative regenerative technology using patients’ own skin cells significantly reduced size of wounds caused by diabetic foot ulcers in all patients Valencia, Calif., USA, and Melbourne, Australia, 01 July 2019 — AVITA Medical (ASX: AVH, OTCQX: AVMXY) a global regenerative medicine company, announced today favorable results from an open-label feasibility study […]
THERMORESPONSIVE 3D CELL CULTURE SCAFFOLDS
/in ElectrospinningLink to Full Article A publication in Acta Biomaterialia by a team at Nottingham University, led by Profs Felicity Rose and Cameron Alexander, describes how a thermoresponsive polymer can be incorporated into 3D cell culture scaffolds to facilitate cell release. This thermoresponsive electrospun scaffold system combines the advantages of providing a physiologically relevant environment to maintain a […]
Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group
/in Saluda MedicalArtarmon, NSW, Australia – June 28, 2019 – Saluda Medical Pty Limited (“Saluda Medical”) today announced that it has secured $75 million in equity financing from Boston Scientific Corporation (NYSE: BSX) and Redmile Group LLC to fund the final stages of development through commercialization of its Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System for […]